 |
K. Christopher Garcia | |
|---|---|
 | |
| Alma mater | Tulane University, Johns Hopkins University |
| Scientific career | |
| Fields | structural biology |
| Institutions | Stanford University |
| Doctoral advisor | Mario Amzel |
| Other academic advisors | David Goeddel, Tony Kossiakoff, Ian Wilson |
K. Christopher Garcia is an American scientist known for his research on the molecular and structural biology of cell surface receptors. Garcia is a professor in the Departments of Molecular and Cellular Physiology and Structural Biology at the Stanford University School of Medicine,[1] an Investigator of the Howard Hughes Medical Institute[2] and a member of the National Academies of Science and Medicine.[3][4] In addition to his role at Stanford, Garcia is a co-founder of several biotechnology companies, including Alexo Therapeutics,[5] Surrozen,[6] and 3T Biosciences.[7]
- ^ Stanford Medicine Profiles - Chris Garcia
- ^ Howard Hughes Medical Institute Scientists - K. Christopher Garcia
- ^ Proceedings of the National Academy of Sciences - Member Details, K. Christopher Garcia
- ^ Press release (2016) - National Academy of Medicine elects 79 new members
- ^ Pitchbook Profile of Alexo Therapeutics
- ^ Yahoo Finance - Surrozen Launches Into Regenerative Medicine
- ^ Farr, Christina (2017-10-04). "Peter Thiel and Sean Parker are financing a secretive cancer-fighting start-up, source says". CNBC. Retrieved 2018-08-28.